Rhythm Pharmaceuticals (RYTM) Operating Leases (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Operating Leases of $3.2 million for Q1 2026, down 17.61% year-over-year from $3.8 million in Q1 2025, and down 5.36% quarter-over-quarter from $3.3 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Operating Leases (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Operating Leases for 6 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 17.61% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 17.61% YoY), while the FY2025 annual figure was $3.3 million, down 15.13% from the prior year.
- Operating Leases retreated to $3.2 million in Q1 2026 per RYTM's latest filing, from $3.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $4.0 million in Q3 2024 and bottomed at $284000.0 in Q1 2024.
- Historically, Operating Leases has averaged $2.3 million across 5 years, with a median of $2.4 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Leases plunged 73.61% — and 2025, when it soared 1251.76%.
- Rhythm Pharmaceuticals' Operating Leases stood at $1.3 million in 2022, then sank by 61.11% to $490000.0 in 2023, then jumped by 703.67% to $3.9 million in 2024, then dropped by 15.13% to $3.3 million in 2025, then declined by 5.36% to $3.2 million in 2026.
- Business Quant data shows RYTM's Operating Leases at $3.2 million in Q1 2026, $3.3 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.98 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 3.52 Mn |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 490,000.00 |
| Sep 30, 2023 | 692,000.00 |
| Jun 30, 2023 | 888,000.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.95 Mn |